PrintThe Burrill Report
The Burrill Report (July 15, 2013): Crescendo Personalizes Rheumatoid Arthritis Disease Management (.MP3,19.25 Mb)
Though the advent of personalized medicine and the changing way doctors treat and manage disease has been most apparent in the area of cancer, new molecular diagnostics are transforming care in many other disease areas. Crescendo Bioscience’s Vectra DA test for rheumatoid arthritis is one such example. We spoke to Crescendo CEO Bill Hagstrom about the test, how it’s changing the way physicians manage and treat RA patients, and how the company has addressed the challenges of adoption and reimbursement.
July 12, 2013
http://www.burrillreport.com/article-crescendo_personalizes_rheumatoid_arthritis_disease_management_.html
PERSONALIZED MEDICINE
Crescendo Personalizes Rheumatoid Arthritis Disease Management
Podcast: July15, 2013[Please login to post comments]
- Life Sciences Companies Up 41 Percent Since IPOs in 2013
Veracyte IPO brings the total to 45 new public companies so far this year, with another 17 in the queue. Read More - Payers Target Rising Specialty Drug Spend
Strategies focus on creating patient-centered models to improve health and economic outcomes. Read More - Paying for Outcomes Extends to Drugs
Agreements can be difficult to administrate, but as payers refine efforts, simplified structures appear to have some staying power. Read More - Why a Tiny Canadian Biotech Suddenly has Big Ambitions
Podcast: November 4, 2013 Read More - Mixed Results for Payer-Pharma Collaborations
HealthCore and Humana don’t see the same return on investment. Read More - Employers Push Workers toward Healthier Choices
Companies control healthcare costs by changing employee behaviors with new tools. Read More - Study Finds Neglected Diseases Remain So
Report warns of a “fatal imbalance in medical R&D.;” Read More - Customer Excellence: Business Model Innovation for MedTechs
Podcast: October 29, 2013 Read More - Glooko Awaits FDA Nod to Expand Diabetes Data Service
By making blood glucose data collection easier, company seeks to improve care management for diabetics. Read More - Practice Fusion Draws Ire over Reviews
Doctors and privacy watchdogs deliver stinging rebuke to company. Read More
.gif)
